Results 161 to 170 of about 340,971 (308)
STING/Type I Interferon Pathway Activation Confers Multimodal Therapeutic Benefits in Osteomyelitis
STING/type I interferon signaling counteracts osteomyelitis through coordinated control of pain, bone destruction, and abscess formation. It inhibits pathogen‐induced nociceptor activation, restrains osteoclast‐mediated bone resorption, and suppresses IL‐1β‐driven neutrophil recruitment.
Yang Chen +19 more
wiley +1 more source
Visual feedback using electrical impedance tomography during inhalation therapy for chronic obstructive lung disease: a pilot study. [PDF]
Stolz S +5 more
europepmc +1 more source
A Robust Bio‐Supportive Hydrogel Patch for Full‐Thickness Repair of Gastroesophageal Defects
Gastroesophageal defect repair remains a formidable clinical challenge plagued by high leakage and life‐threatening complications. We develop a double‐disc, highly crystalline PVA‐based RBS hydrogel patch featuring suture‐free sealing, robust acid/enzyme resistance and mechanical durability.
Xingqi Song +13 more
wiley +1 more source
Ziying Jiang,1,* Xinzuo Qin,1,* Xiao Wu,1,* Zijian Wang,1 Xinyu Wang,1 Lingqian He,1 Mingji Cuomu,2 Zhinan Mei,3 Hongping Hou,4 Haiqing Song,1 Juexian Song1 1Department of Neurology, Xuanwu Hospital, Capital Medical University ...
Jiang Z +10 more
doaj
Aerosolized prostaglandin E<sub>1</sub> improves oxygenation during one-lung ventilation: A dose-finding randomized controlled trial. [PDF]
Li P +6 more
europepmc +1 more source
This study reveals that large tumors secrete more chemokine CXCL3, which recruits immunosuppressive neutrophils to the periphery, thereby impairing the activation and memory of systemic tumor‑reactive CD8+ T cells. CXCL3 antagonism restores systemic immune memory and enhances the antitumor efficacy of anti‑PD‑1 therapy, offering a potential strategy to
Ji Wang +15 more
wiley +1 more source
Artificial Intelligence-Based Optimization of Pulmonary Drug Delivery Performance in Smart Inhaler Drug-Device Combination Systems. [PDF]
Pawar HB +4 more
europepmc +1 more source

